Skip to main content
Premium Trial:

Request an Annual Quote

Ipsum Diagnostics Coronavirus Test Gets FDA Emergency Use Authorization

NEW YORK — The US Food and Drug Administration on Wednesday granted Emergency Use Authorization to Ipsum Diagnostics for the company's RT-PCR-based SARS-CoV-2 test.

According to the FDA, the test, called COV-19 IDx, is designed to detect a region in the SARS-CoV-2 nucleocapsid gene, as well as human RNase P as a control, in nasopharyngeal and oropharyngeal swab specimens. Nucleic acid extraction is performed using Thermo Fisher Scientific's KingFisher Flex nucleic acid extraction system and the Omega Bio-Tek Mag-Bind Viral DNA/RNA 96 kit, and the test runs on Thermo Fisher's Applied Biosystems QuantStudio 12 K Flex instrument.

Emergency use of the test is limited to Ipsum and other authorized laboratories, the FDA noted.

Atlanta-based Ipsum is offering COV-19 IDx supplies and kits via a physician portal on its website

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.